The interplay between fiber and the intestinal microbiome in the inflammatory response

Advances in Nutrition

Volumn 4, Issue 1, 2013, Pages 16-28

  Kuo, Shiu Ming ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; INULIN; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ANIMAL; ANIMAL MODEL; BODY WEIGHT; CROHN DISEASE; DIET; DIET SUPPLEMENTATION; DIETARY FIBER; HUMAN; INFLAMMATION; INTESTINE; METABOLISM; METAGENOME; OBESITY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CROHN DISEASE; DIET; DIETARY FIBER; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATION; INTESTINES; INULIN; METAGENOME; MODELS, ANIMAL; OBESITY; PROBIOTICS; SYNBIOTICS;

MLCS; MLOWN;

EID: 84879447578     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.112.003046     Document Type: Review

References (162)

1. Otten JJ, Hellwig JP, Meyers LD. DRI, dietary reference intakes [electronic resource]: the essential guide to nutrient requirements. Washington, DC: National Academies Press; 2006.
2. Bieri JG, Stoewsand GS, Briggs GM, Phillips RW, Woodard JC, Knapka JJ. Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr. 1977;107:1340-8.
3. Reeves PG, Nielsen FH, Fahey GCJ. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-51.
4. Spiller GA, Amen R. Letter: Plant fibers in nutrition: need for better nomenclature. Am J Clin Nutr. 1975;28:675-6.
5. Spiller GA, Fassett-Cornelius G, Briggs G. Letter: a new term for plant fibers in nutrition. Am J Clin Nutr. 1976;29:934-5.
6. Lattimer JM, Haub M. Effects of dietary fiber and its components on metabolic health. Nutrients. 2010;2:1266-89.
7. Clemens R, Kranz S, Mobley A, Nicklas T, Raimondi M, Rodriguez J, Slavin J, Warshaw H. Filling America's fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods. J Nutr. 2012;142:1390S-401S.
8. Kranz S, Brauchla M, Slavin J, Miller K. What do we know about dietary fiber intake in children and health? The effects of fiber intake on constipation, obesity, and diabetes in children. Adv Nutr. 2012;3: 47-53.
9. Valledor AF, Comalada M, Santamaría-Babi L, Lloberas J, Celada A. Macrophage proinflammatory activation and deactivation: a question of balance. Adv Immunol. 2010;108:1-20.
10. Mountziaris PM, Spicer P, Kasper F, Mikos A. Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev. 2011;17:393-402.
11. Brownawell AM, Caers W, Gibson G, Kendall C, Lewis K, Ringel Y, Slavin J. Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr. 2012;142:962-74.
12. Kay RM. Dietary fiber. J Lipid Res. 1982;23:221-42.
13. Walter J, Ley R. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol. 2011;65:411-29.
14. Fleming SE, Rodriguez M. Influence of dietary fiber on fecal excretion of volatile fatty acids by human adults. J Nutr. 1983;113:1613-25.
15. Bourquin LD, Titgemeyer E, Fahey GJ, Garleb K. Fermentation of dietary fibre by human colonic bacteria: disappearance of, short-chain fatty acid production from, and potential water-holding capacity of, various substrates. Scand J Gastroenterol. 1993;28:249-55.
16. van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. Inulintype fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol. 2007;102:452-60.
17. Kaur A, Rose D, Rumpagaporn P, Patterson J, Hamaker B. In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using "slowly fermentable" dietary fibers. J Food Sci. 2011;76:H137-42.
18. Swanson KS, Grieshop C, Clapper G, Shields RJ, Belay T, Merchen N, Fahey GJ. Fruit and vegetable fiber fermentation by gut microflora from canines. J Anim Sci. 2001;79:919-26.
19. Vernazza CL, Gibson G, Rastall R. Carbohydrate preference, acid tolerance and bile tolerance in five strains of Bifidobacterium. J Appl Microbiol. 2006;100:846-53.
20. Marcobal A, Sonnenburg J. Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect. 2012;18: Suppl 4:12-5.
21. Bolam DN, Sonnenburg J. Mechanistic insight into polysaccharide use within the intestinal microbiota. Gut Microbes. 2011;2:86-90.
22. Morita T, Kasaoka S, Hase K, Kiriyama S. Psyllium shifts the fermentation site of high-amylose cornstarch toward the distal colon and increases fecal butyrate concentration in rats. J Nutr. 1999;129:2081-7.
23. Benson AK, Kelly S, Legge R, Ma F, Low S, Kim J, Zhang M, Oh P, Nehrenberg D, Hua K, et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A. 2010;107:18933-8.
24. Yatsunenko T, Rey F, ManaryM, Trehan I, Dominguez-BelloM, Contreras M, Magris M, Hidalgo G, Baldassano R, Anokhin A, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486: 222-7.
25. Campbell JH, Foster C, Vishnivetskaya T, Campbell A, Yang Z, Wymore A, Palumbo A, Chesler E, Podar M. Host genetic and environmental effects on mouse intestinal microbiota. ISME J. 2012;6: 2033-44.
26. Claesson MJ, Jeffery I, Conde S, Power S, O'Connor E, Cusack S, Harris H, Coakley M, Lakshminarayanan B, O'Sullivan O, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488:178-84.
27. Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C, Waget A, Klopp P, Iacovoni J, Klopp C, et al. Metabolic adaptation to a highfat diet is associated with a change in the gut microbiota. Gut. 2012;61:543-53.
28. Fava F, Gitau R, Griffin B, Gibson G, Tuohy K, Lovegrove J. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population. Int J Obes (Lond). Epub 2012 Mar 13.
29. de Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, de Vogel-van den Bosch J, Kleerebezem M, Müller M, van der Meer R. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol. 2012;303:G589-99.
30. Kolida S, Gibson G. Prebiotic capacity of inulin-type fructans. J Nutr. 2007;137:2503S-6S.
31. Joossens M, Huys G, Van Steen K, Cnockaert M, Vermeire S, Rutgeerts P, Verbeke K, Vandamme P, De Preter V. High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake. FEMS Microbiol Ecol. 2011;75:343-9.
32. Costabile A, Kolida S, Klinder A, Gietl E, Bäuerlein M, Frohberg C, Landschütze V, Gibson G. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-longchain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr. 2010;104:1007-17.
33. Koleva PT, Valcheva R, Sun X, Gänzle M, Dieleman L. Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats. Br J Nutr. 2012;16:1-11.
34. Langlands SJ, Hopkins M, Coleman N, Cummings J. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut. 2004;53:1610-6.
35. Boler BM, Serao M, Bauer L, Staeger M, Boileau T, Swanson K, Fahey GJ. Digestive physiological outcomes related to polydextrose and soluble maize fibre consumption by healthy adult men. Br J Nutr. 2011; 106:1864-71.
36. Martínez I, Kim J, Duffy P, Schlegel V, Walter J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS ONE. 2010;5:e15046.
37. Davis LM, Martínez I, Walter J, Goin C, Hutkins R. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS ONE. 2011;6:e25200.
38. Hooda S, Boler B, Serao M, Brulc J, Staeger M, Boileau T, Dowd S, Fahey GJ, Swanson K. 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. J Nutr. 2012;142:1259-65.
39. Hernández-Hernández O, Marín-Manzano M, Rubio L, Moreno F, Sanz M, Clemente A. Monomer and linkage type of galacto-oligosaccharides affect their resistance to ileal digestion and prebiotic properties in rats. J Nutr. 2012;142:1232-9.
40. Roberfroid M. Prebiotics: the concept revisited. J Nutr. 2007;137 Suppl 2:830S-7S.
41. Park Y, Subar A, Hollenbeck A, Schatzkin A. Dietary fiber intake and mortality in the NIH-AARP Diet and Health Study. Arch Intern Med. 2011;171:1061-8.
42. Chuang SC, Norat T, Murphy N, Olsen A, Tjønneland A, Overvad K, Boutron-Ruault M, Perquier F, Dartois L, Kaaks R, et al. Fiber intake and total and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr. 2012;96:164-74.
43. Stienstra R, Tack C, Kanneganti T, Joosten L, Netea M. The inflammasome puts obesity in the danger zone. Cell Metab. 2012;15:10-8.
44. Fresno M, Alvarez R, Cuesta N. Toll-like receptors, inflammation, metabolism and obesity. Arch Physiol Biochem. 2011;117:151-64.
45. Farmer B, Larson BT, Fulgoni VL 3rd, Rainville AJ, Liepa GU. A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the national health and nutrition examination survey 1999-2004. J Am Diet Assoc. 2011;111:819-27.
46. Shay CM, Van Horn L, Stamler J, Dyer A, Brown I, Chan Q, Miura K, Zhao L, Okuda N, Daviglus M, et al. Food and nutrient intakes and their associations with lower BMI in middle-aged US adults: the International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP). Am J Clin Nutr. 2012;96:483-91.
47. Ley RE, Turnbaugh P, Klein S, Gordon J. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022-3.
48. Turnbaugh PJ, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31.
49. Jumpertz R, Le D, Turnbaugh P, Trinidad C, Bogardus C, Gordon J, KrakoffJ. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr. 2011;94:58-65.
50. Amini M, Esmaillzadeh A, Shafaeizadeh S, Behrooz J, Zare M. Relationship between major dietary patterns and metabolic syndrome among individuals with impaired glucose tolerance. Nutrition. 2010; 26:986-92.
51. Rizzo NS, Sabaté J, Jaceldo-Siegl K, Fraser G. Vegetarian dietary patterns are associated with a lower risk of metabolic syndrome: the adventist health study 2. Diabetes Care. 2011;34:1225-7.
52. Ajani UA, Ford E, Mokdad A. Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. J Nutr. 2004;134:1181-5.
53. Herder C, Peltonen M, Koenig W, Sütfels K, Lindström J, Martin S, Ilanne-Parikka P, Eriksson J, Aunola S, Keinänen-Kiukaanniemi S, et al. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia. 2009;52:433-42.
54. Estruch R, Martínez-González M, Corella D, Basora-Gallisá J, Ruiz- Gutiérrez V, Covas M, Fiol M, Gómez-Gracia E, López-Sabater M, Escoda R, et al. Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. J Epidemiol Community Health. 2009; 63:582-8.
55. Galisteo M, Sánchez M, Vera R, González M, Anguera A, Duarte J, Zarzuelo A. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. J Nutr. 2005;135:2399-404.
56. Sánchez D, Quiñones M, Moulay L, Muguerza B, Miguel M, Aleixandre A. Soluble fiber-enriched diets improve inflammation and oxidative stress biomarkers in Zucker fatty rats. Pharmacol Res. 2011;64:31-5.
57. Cani PD, Neyrinck A, Fava F, Knauf C, Burcelin R, Tuohy K, Gibson G, Delzenne N. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374-83.
58. Dewulf EM, Cani P, Neyrinck A, Possemiers S, Van Holle A, Muccioli G, Deldicque L, Bindels L, Pachikian B, Sohet F, et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARg-related adipogenesis in the white adipose tissue of highfat diet-fed mice. J Nutr Biochem. 2011;22:712-22.
59. Sugatani J, Wada T, Osabe M, Yamakawa K, Yoshinari K, Miwa M. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression. Drug Metab Dispos. 2006;34:1677-87.
60. Neyrinck AM, Alexiou H, Delzenne N. Kupffer cell activity is involved in the hepatoprotective effect of dietary oligofructose in rats with endotoxic shock. J Nutr. 2004;134:1124-9.
61. Qi L, van Dam R, Liu S, Franz M, Mantzoros C, Hu F. Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care. 2006;29:207-11.
62. Villaseñor A, Ambs A, Ballard-Barbash R, Baumgartner K, McTiernan A, Ulrich C, Neuhouser M. Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study. Breast Cancer Res Treat. 2011;129:485-94.
63. Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek EJ 3rd, Li W, Pagoto SL, Hafner AR, Ockene IS. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr. 2006;83: 760-6.
64. Ma Y, Hébert JR, Li W, Bertone-Johnson ER, Olendzki B, Pagoto SL, Tinker L, Rosal MC, Ockene IS, Ockene JK, et al. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition. 2008;24:941-9.
65. Chuang SC, Vermeulen R, Sharabiani M, Sacerdote C, Fatemeh S, Berrino F, Krogh V, Palli D, Panico S, Tumino R, et al. The intake of grain fibers modulates cytokine levels in blood. Biomarkers. 2011;16:504-10.
66. King DE, Mainous AG 3rd, Egan BM, Woolson RF, Geesey ME. Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med. 2008;6:100-6.
67. Theuwissen E, Plat J, Mensink R. Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol Nutr Food Res. 2009;53:370-6.
68. Worthley DL, Le Leu R, Whitehall V, Conlon M, Christophersen C, Belobrajdic D, Mallitt K, Hu Y, Irahara N, Ogino S, et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr. 2009;90:578-86.
69. King D, Egan B, Woolson R, Mainous AG 3rd, Al-Solaiman Y, Jesri A. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007;167:502-6.
70. Benjamin JL, Hedin C, Koutsoumpas A, Ng S, McCarthy N, Hart A, Kamm M, Sanderson J, Knight S, Forbes A, et al. Randomised, double- blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut. 2011;60:923-9.
71. Kanauchi O, Mitsuyama K, Homma T, Takahama K, Fujiyama Y, Andoh A, Araki Y, Suga T, Hibi T, Naganuma M, et al. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. Int J Mol Med. 2003;12:701-4.
72. Faghfoori Z, Navai L, Shakerhosseini R, Somi M, Nikniaz Z, Norouzi M. Effects of an oral supplementation of germinated barley foodstuffon serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis. Ann Clin Biochem. 2011;48:233-7.
73. Schiffrin EJ, Thomas D, Kumar V, Brown C, Hager C, Van't Hof M, Morley J, Guigoz Y. Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. J Nutr Health Aging. 2007;11:475-9.
74. Arslanoglu S, Moro G, Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr. 2007;137:2420-4.
75. Arslanoglu S, Moro G, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138:1091-5.
76. Shadid R, Haarman M, Knol J, Theis W, Beermann C, Rjosk-Dendorfer D, Schendel D, Koletzko B, Krauss-Etschmann S. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity-a randomized, double-blind, placebo-controlled study. Am J Clin Nutr. 2007;86:1426-37.
77. Westerbeek EA, van den Berg J, Lafeber H, Fetter W, Boehm G, Twisk J, van Elburg R. Neutral and acidic oligosaccharides in preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2010;91:679-86.
78. van Stuijvenberg M, Eisses A, Grüber C, Mosca F, Arslanoglu S, Chirico G, Braegger C, Riedler J, Boehm G, Sauer P. Do prebiotics reduce the number of fever episodes in healthy children in their first year of life: a randomised controlled trial. Br J Nutr. 2011;106:1740-8.
79. Moreau NM, Toquet C, Laboisse C, Nguyen P, Siliart B, Champ M, Dumon H, Martin L. Predominance of caecal injury in a new dextran sulphate sodium treatment in rats: histopathological and fermentative characteristics. Eur J Gastroenterol Hepatol. 2002;14:535-42.
80. Cherbut C, Michel C, Lecannu G. The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J Nutr. 2003;133:21-7.
81. Lara-Villoslada F, de Haro O, Camuesco D, Comalada M, Velasco J, Zarzuelo A, Xaus J, Galvez J. Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr. 2006;45:418-25.
82. Rodríguez-Cabezas ME, Camuesco D, Arribas B, Garrido-Mesa N, Comalada M, Bailón E, Cueto-Sola M, Utrilla P, Guerra-Hernández E, Pérez-Roca C, et al. The combination of fructooligosaccharides and resistant starch shows prebiotic additive effects in rats. Clin Nutr. 2010;29:832-9.
83. Winkler J, Butler R, Symonds E. Fructo-oligosaccharide reduces inflammation in a dextran sodium sulphate mouse model of colitis. Dig Dis Sci. 2007;52:52-8.
84. Goto H, Takemura N, Ogasawara T, Sasajima N, Watanabe J, Ito H, Morita T, Sonoyama K. Effects of fructo-oligosaccharide on DSSinduced colitis differ in mice fed nonpurified and purified diets. J Nutr. 2010;140:2121-7.
85. Moreau NM, Martin L, Toquet C, Laboisse C, Nguyen P, Siliart B, Dumon H, Champ M. Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis. Br J Nutr. 2003;90: 75-85.
86. Boehm G, Stahl B. Oligosaccharides from milk. J Nutr. 2007;137: 847S-9S.
87. Rumi G, Tsubouchi R, Okayama M, Kato S, Mózsik G, Takeuchi K. Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig Dis Sci. 2004;49:1466-72.
88. Lara-Villoslada F, Debras E, Nieto A, Concha A, Gálvez J, López- Huertas E, Boza J, Obled C, Xaus J. Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin Nutr. 2006;25:477-88.
89. Camuesco D, Peran L, Comalada M, Nieto A, Di Stasi L, Rodriguez- Cabezas M, Concha A, Zarzuelo A, Galvez J. Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm Bowel Dis. 2005;11:265-71.
90. Naito Y, Takagi T, Katada K, Uchiyama K, Kuroda M, Kokura S, Ichikawa H, Watabe J, Yoshida N, Okanoue T, et al. Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. J Nutr Biochem. 2006;17:402-9.
91. Komiyama Y, Andoh A, Fujiwara D, Ohmae H, Araki Y, Fujiyama Y, Mitsuyama K, Kanauchi O. New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system. Scand J Gastroenterol. 2011;46:40-52.
92. Fukuda M, Kanauchi O, Araki Y, Andoh A, Mitsuyama K, Takagi K, Toyonaga A, Sata M, Fujiyama Y, Fukuoka M, et al. Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int J Mol Med. 2002;9:65-70.
93. Mochizuki M, Shigemura H, Hasegawa N. Anti-inflammatory effect of enzymatic hydrolysate of corn gluten in an experimental model of colitis. J Pharm Pharmacol. 2010;62:389-92.
94. Kanauchi O, Iwanaga T, Andoh A, Araki Y, Nakamura T, Mitsuyama K, Suzuki A, Hibi T, Bamba T. Dietary fiber fraction of germinated barley foodstuffattenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis. J Gastroenterol Hepatol. 2001;16:160-8.
95. Smith CL, Geier M, Yazbeck R, Torres D, Butler R, Howarth G. Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats. Nutr Cancer. 2008;60:757-67.
96. Taurog JD, Maika S, Satumtira N, Dorris M, McLean I, Yanagisawa H, Sayad A, Stagg A, Fox G, Lê O'Brien A, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev. 1999;169:209-23.
97. Hoentjen F, Welling G, Harmsen H, Zhang X, Snart J, Tannock G, Lien K, Churchill T, Lupicki M, Dieleman L. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 2005;11: 977-85.
98. Rodríguez-Cabezas ME, Gálvez JC, Calmuesco D, Lorente MD, Concha A, Martinez-Augustin O, Redondo L, Zarzuelo A. Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats. Clin Nutr. 2003;22:463-71.
99. Bassaganya-Riera J, DiGuardo M, Viladomiu M, de Horna A, Sanchez S, Einerhand A, Sanders L, Hontecillas R. Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease. J Nutr. 2011;141:1318-25.
100. Kühn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin- 10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-74.
101. Hirano D, Kudo S. Usefulness of CD4+CD45RBhigh CD25-celltransferred SCID mice for preclinical evaluation of drugs for inflammatory bowel disease. J Pharmacol Sci. 2009;110:169-81.
102. Kanauchi O, Oshima T, Andoh A, Shioya M, Mitusuyama K. Germinated barley foodstuffameliorates inflammation in mice with colitis through modulation of mucosal immune system. Scand J Gastroenterol. 2008;43:1346-52.
103. Kau AL, Ahern P, Griffin N, Goodman A, Gordon J. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474: 327-36.
104. Yasuda A, Inoue K, Sanbongi C, Yanagisawa R, Ichinose T, Yoshikawa T, Takano H. Dietary supplementation with fructooligosaccharides attenuates airway inflammation related to house dust mite allergen in mice. Int J Immunopathol Pharmacol. 2010;23:727-35.
105. Yasuda A, Inoue K, Sanbongi C, Yanagisawa R, Ichinose T, Tanaka M, Yoshikawa T, Takano H. Dietary supplementation with fructooligosaccharides attenuates allergic peritonitis in mice. Biochem Biophys Res Commun. 2012;422:546-50.
106. Vos AP, van Esch B, Stahl B, M'Rabet L, Folkerts G, Nijkamp F, Garssen J. Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int Immunopharmacol. 2007;7:1582-7.
107. Watanabe J, Sasajima N, Aramaki A, Sonoyama K. Consumption of fructo-oligosaccharide reduces 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice. Br J Nutr. 2008;100:339-46.
108. Fujiwara R, Sasajima N, Takemura N, Ozawa K, Nagasaka Y, Okubo T, Sahasakul Y, Watanabe J, Sonoyama K. 2,4-Dinitrofluorobenzeneinduced contact hypersensitivity response in NC/Nga mice fed fructo- oligosaccharide. J Nutr Sci Vitaminol (Tokyo). 2010;56:260-5.
109. Fujiwara R, Takemura N, Watanabe J, Sonoyama K. Maternal consumption of fructo-oligosaccharide diminishes the severity of skin inflammation in offspring of NC/Nga mice. Br J Nutr. 2010;103:530-8.
110. Grabitske HA, Slavin J. Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr. 2009;49:327-60.
111. Alastair F, Emma G, Emma P. Nutrition in inflammatory bowel disease. JPEN J Parenter Enteral Nutr. 2011;35:571-80.
112. Mahendran V, Riordan S, Grimm M, Tran T, Major J, Kaakoush N, Mitchell H, Zhang L. Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS ONE. 2011;6:e25417.
113. Li Q, Wang C, Tang C, Li N, Li J. Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease. PLoS ONE. 2012;7:e34939.
114. Boyle RJ, Robins-Browne R, Tang M. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006;83:1256-64.
115. Kolida S, Gibson G. Synbiotics in health and disease. Annu Rev Food Sci Technol. 2011;2:373-93.
116. Seifert S, Bub A, Franz C, Watzl B. Probiotic Lactobacillus casei Shirota supplementation does not modulate immunity in healthy men with reduced natural killer cell activity. J Nutr. 2011;141:978-84.
117. Lam V, Su J, Koprowski S, Hsu A, Tweddell J, Rafiee P, Gross G, Salzman N, Baker J. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 2012;26:1727-35.
118. Liu YW, Su Y, Ong W, Cheng T, Tsai Y. Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities. Int Immunopharmacol. 2011;11:2159-66.
119. Ganesh BP, Richter J, Blaut M, Loh G. Enterococcus faecium NCIMB 10415 does not protect interleukin-10 knock-out mice from chronic gut inflammation. Benef Microbes. 2012;3:43-50.
120. Passariello A, Terrin G, Cecere G, Micillo M, De Marco G, Di Costanzo M, Cosenza L, Leone L, Nocerino R, Canani R. Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea. Aliment Pharmacol Ther. 2012;35:782-8.
121. Vandenplas Y, De Hert S. Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children. Aliment Pharmacol Ther. 2011;34:862-7.
122. Jain PK, McNaught C, Anderson A, MacFie J, Mitchell C. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr. 2004;23:467-75.
123. Schrezenmeir J, Heller K, McCue M, Llamas C, Lam W, Burow H, Kindling-Rohracker M, FischerW, Sengespeik H, Comer G, et al. Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections. Clin Pediatr (Phila). 2004; 43:239-49.
124. Furrie E, Macfarlane S, Kennedy A, Cummings J, Walsh S, O'Neil D, Macfarlane G. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 2005;54:242-9.
125. van der Aa LB, Lutter R, Heymans H, Smids B, Dekker T, van Aalderen W, Sillevis Smitt J, Knippels L, Garssen J, Nauta A, et al. No detectable beneficial systemic immunomodulatory effects of a specific synbiotic mixture in infants with atopic dermatitis. Clin Exp Allergy. 2012;42: 531-9.
126. Shafiei A, Moin M, Pourpak Z, Gharagozlou M, Aghamohammadi A, Sajedi V, Soheili H, Sotoodeh S, Movahedi M. Synbiotics could not reduce the scoring of childhood atopic dermatitis (SCORAD): a randomized double blind placebo-controlled trial. Iran J Allergy Asthma Immunol. 2011;10:21-8.
127. Wu KG, Li T, Peng H. Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety. Br J Dermatol. 2012;166: 129-36.
128. Kuo SM, Burl L, Hu Z. Cellular phenotype-dependent and -independent effects of vitamin C on the renewal and gene expression of mouse embryonic fibroblasts. PLoS ONE. 2012;7:e32957.
129. DiDonato JA, Mercurio F, Karin M. NF-kB and the link between inflammation and cancer. Immunol Rev. 2012;246:379-400.
130. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson P, Klinder A, O'Riordan M, O'Sullivan G, Pool-Zobel B, et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 2007;85:488-96.
131. Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr. 2007;97:676-84.
132. Roller M, Rechkemmer G, Watzl B. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr. 2004;134:153-6.
133. Schultz M, Munro K, Tannock G, Melchner I, Göttl C, Schwietz H, Schölmerich J, Rath H. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clin Diagn Lab Immunol. 2004;11:581-7.
134. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins K, Paglierani M, Caderni G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis. 2002;23:1953-60.
135. Le Leu RK, Hu Y, Brown I, Woodman R, Young G. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis. 2010;31:246-51.
136. Håkansson A, Bränning C, Adawi D, Molin G, Nyman M, Jeppsson B, Ahrné S. Blueberry husks, rye bran and multi-strain probiotics affect the severity of colitis induced by dextran sulphate sodium. Scand J Gastroenterol. 2009;44:1213-25.
137. Håkansson A, Bränning C, Molin G, Adawi D, Hagslätt M, Jeppsson B, Nyman M, Ahrné S. Blueberry husks and probiotics attenuate colorectal inflammation and oncogenesis, and liver injuries in rats exposed to cycling DSS-treatment. PLoS ONE. 2012;7:e33510.
138. Foye OT, Huang I, Chiou C, Walker W, Shi H. Early administration of probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates pathogen-mediated intestinal inflammation and Smad 7 cell signaling. FEMS Immunol Med Microbiol. 2012;65:467-80.
139. Zenhom M, Hyder A, de Vrese M, Heller K, Roeder T, Schrezenmeir J. Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARg and peptidoglycan recognition protein 3. J Nutr. 2011;141:971-7.
140. Shoaf K, Mulvey G, Armstrong G, Hutkins R. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun. 2006;74:6920-8.
141. Quintero M, Maldonado M, Perez-Munoz M, Jimenez R, Fangman T, Rupnow J, Wittke A, Russell M, Hutkins R. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides. Curr Microbiol. 2011;62:1448-54.
142. Aluwihare AP. An ultrastructural study of the effect of neomycin on the colon in the human subject and in the conventional and the germ-free mouse. Gut. 1971;12:341-9.
143. Bäckhed F, Manchester J, Semenkovich C, Gordon J. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007;104:979-84.
144. Ceuppens S, Van de Wiele T, Rajkovic A, Ferrer-Cabaceran T, Heyndrickx M, Boon N, Uyttendaele M. Impact of intestinal microbiota and gastrointestinal conditions on the in vitro survival and growth of Bacillus cereus. Int J Food Microbiol. 2012;155:241-6.
145. Veiga P, Gallini C, Beal C, Michaud M, Delaney M, DuBois A, Khlebnikov A, van Hylckama Vlieg J, Punit S, Glickman J, et al. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A. 2010;107:18132-7.
146. Jurjus AR, Khoury N, Reimund J. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004;50:81-92.
147. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol. 2010;8:564-77.
148. Han DY, Fraser A, Dryland P, Ferguson L. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res. 2010;690:116-22.
149. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, Orandle M, Mayer L, Macpherson A, McCoy K, et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med. 2011;17: 1585-93.
150. Maslowski KM, Mackay C. Diet, gut microbiota and immune responses. Nat Immunol. 2011;12:5-9.
151. Hooper LV, Littman D, Macpherson A. Interactions between the microbiota and the immune system. Science. 2012;336:1268-73.
152. Noverr MC, Huffnagle G. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 2004;12:562-8.
153. Noverr MC, Noggle R, Toews G, Huffnagle G. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun. 2004;72:4996-5003.
154. Noverr MC, Falkowski N, McDonald R, McKenzie A, Huffnagle G. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect Immun. 2005;73:30-8.
155. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, JiaW, Pettersson S. Host-gut microbiota metabolic interactions. Science. 2012;336: 1262-7.
156. WikoffWR, Anfora A, Liu J, Schultz P, Lesley S, Peters E, Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009;106:3698-703.
157. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, Zhang Y, Shen J, Pang X, Zhang M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A. 2008;105:2117-22.
158. Samuel BS, Shaito A, Motoike T, Rey F, Backhed F, Manchester J, Hammer R, Williams S, Crowley J, Yanagisawa M, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A. 2008;105:16767-72.
159. Araki Y, Fujiyama Y, Andoh A, Koyama S, Kanauchi O, Bamba T. The dietary combination of germinated barley foodstuffplus Clostridium butyricum suppresses the dextran sulfate sodium-induced experimental colitis in rats. Scand J Gastroenterol. 2000;35:1060-7.
160. Nilsson AC, Östman E, Knudsen K, Holst J, Björck I. A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning. J Nutr. 2010;140:1932-6.
161. Zimmerman MA, Singh N, Martin P, Thangaraju M, Ganapathy V, Waller J, Shi H, Robertson K, Munn D, Liu K. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1405-15.
162. Gonçalves P, Araújo J, Pinho M, Martel F. In vitro studies on the inhibition of colon cancer by butyrate and polyphenolic compounds. Nutr Cancer. 2011;63:282-94.